Biotage Takes Yet Another Step in Streamlining Efforts.- Outsources All Instrument Production to Contract Manufacturers STOCKHOLM, Sweden -- Regulatory News: Biotage (STO:BIOTA) has made the decision to transfer instrument production from its Charlottesville, VA factory in the U.S. to a contract manufacturer. Through this decision, the company takes yet another step to increase efficiency in business activities. Biotage expects this measure to enable substantial cost savings, a reduction in tied-up capital and increased flexibility. Biotage currently has two internal production units. The majority of the consumables Biotage offers its customers are manufactured at the company's factory in Cardiff, Wales Wales, Welsh Cymru, western peninsula and political division (principality) of Great Britain (1991 pop. 2,798,200), 8,016 sq mi (20,761 sq km), west of England; politically united with England since 1536. The capital is Cardiff. . The Charlottesville, VA factory manufactures instruments primarily within the Purification product segment as well as a small portion of consumables. The remaining part of its instrument production is outsourced to a subcontractor One who takes a portion of a contract from the principal contractor or from another subcontractor. When an individual or a company is involved in a large-scale project, a contractor is often hired to see that the work is done. since previously. "In recent years, we have pursued a successful undertaking to optimize our business activities. One important component of this effort is to streamline production. By moving production from Charlottesville, we achieve considerable efficiency gains and reduce susceptibility susceptibility the state of being susceptible. Refers usually to infectious disease but may be to physical factors such as wetting or to psychological factors such as harassment. to changes in demand," says Torben Jorgensen, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Biotage. In conjunction with this relocation of instrument production, the Charlottesville consumables production will be moved to the Biotage factory in Cardiff, providing additional large-scale benefits. The transfer of production from Charlottesville will be implemented in stages and completion is estimated for the fourth quarter of 2009. This decision means that the factory will be closing and the company's U.S. workforce will decrease by approximately 50 employees. About Biotage Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the area of medicinal chemistry Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs. . In 2005 business and products from the company Argonaut were acquired, further strengthening the product range in medicinal chemistry. The customers include the worlds top 30 pharma companies, the worlds top 20 biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the U.S., Japan, UK, Germany and several other European countries. Biotage has 300 employees and had sales of SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 496m in 2007. Biotage is listed on the OMX OMX Office Max (stock symbol) Nordic stock exchange. Website: www.biotage.com This information was brought to you by Cision http://www.cisionwire.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion